|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/501 | (2006.01) |
| A61P 25/00 | (2006.01) | ||
| A61P 25/14 | (2006.01) |
| (11) | Number of the document | 3113778 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15709324.6 |
| Date of filing the European patent application | 2015-03-06 | |
| (97) | Date of publication of the European application | 2017-01-11 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-06 |
| (46) | Date of publication of the claims translation | 2018-08-27 |
| (86) | Number | PCT/GB2015/050654 |
| Date | 2015-03-06 |
| (87) | Number | WO 2015/132608 |
| Date | 2015-09-11 |
| (30) | Number | Date | Country code |
| 201403944 | 2014-03-06 | GB |
| (72) |
ALMOND, Sarah, GB
|
| (73) |
Takeda Pharmaceutical Company Limited,
1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045,
JP
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Piridazino dariniai, skirti naudoti ataksinio sutrikimo profilaktikai arba gydymui |
| PYRIDAZINE DERIVATIVES FOR USE IN THE PREVENTION OR TREATMENT OF AN ATAXIC DISORDER |
| Payment date | Validity (years) | Amount | |
| 2022-02-21 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-03-06 |